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Abstract: (1) Background: Diabetic peripheral neuropathy (DPN) is one of the most common com-
plications of diabetes mellitus (DM). Control of hyperglycaemia as well as surgical decompression
are effective treatments for these patients. However, surgery is not indicated for all candidates.
Manual therapy and physical exercise have been shown to be effective for peripheral neuropathies,
and exercise for DM. The aim is to review the effectiveness of manual therapy and/or exercise
in patients with DPN. (2) Methods: Randomised controlled clinical trials comparing the effects of
manual therapy and/or exercise on pain, function and/or balance were selected. The search strategy
was performed in PubMed, PEDro, Scopus, Cochrane and Web of Science databases. The PRISMA
statement was followed. (3) Results: A total of 656 articles were registered, and 29 were selected.
There was little consensus on DPN criteria selection. Aerobic, strength and balance exercises are
beneficial for DPN. Sessions of 30–60 min, three times per week for 8 weeks seems to be the most
used dose. Manual therapy is effective in the short term. A combination of both modalities was more
beneficial than alone in one study. (4) Conclusions: Exercise and manual therapy are beneficial for
patients with DPN. More studies should be carried out for analysing the potential effect of combining
manual therapy and exercise.
Keywords: diabetes mellitus; diabetic neuropathies; exercise; manual therapy
1. Introduction
Diabetes mellitus is a heterogeneous metabolic disease characterised by hypergly-
caemia as a result of defects in insulin secretion, in insulin action or in both [1]. It is one of
the most common chronic diseases, with an estimated prevalence of 366 million patients
in 2030 [2]. Peripheral neuropathy is one of the most common complications of diabetic
patients, with 25–50% being affected, especially with type 2 diabetes [3–5]. Peripheral
neuropathy is known as the injury of small- or large-diameter nerve fibres of the peripheral
nervous system, resulting in altered motor, sensory, vibration and proprioception functions
for large fibres, and pain, temperature and autonomic function for small fibres [6].
The pathophysiology of diabetic neuropathy is multifactorial, with influence from
genetic, environmental, behavioural, metabolic, neurotrophic and even vascular fac-
tors [7]. The potential mechanisms of the nerve lesions in diabetes include hyperglycaemia
(toxic/reactive metabolites stemming from the hyperglycaemia), microangiopathy and
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ischemia, cell signalling anomalies due to diacylglycerol and to protein kinase C, sodium
channel deregulation and demyelination [8]. Hyperglycaemia is the main factor of risk in
the various types of diabetes, provoking lesions by microvascular and metabolic alterations.
These vascular changes damage the primary sensory nerves through neuronal hypoxia
and nutrient deficits [8,9]. The neural lesion occurs in both long and short fibres indis-
criminately, with a differentiated clinical presentation in both cases. The most frequent
alterations are produced in short fibres.
There is evidence that strict blood glucose control is effective in halting progression to
diabetic neuropathy [10], as it controls the hyperglycaemic component of these patients.
Invasive treatment, such as surgical decompression, can be useful for relieving neuropathic
symptoms in some patients. However, not all diabetic patients with neuropathy are candi-
dates for nerve decompression [4]. Conservative treatment such as exercising, receiving
transcutaneous electrical nerve stimulation (TENS) and taking vitamin D supplements
have been shown to be beneficial in reducing pain and improving function and balance in
these patients [3,11,12].
During exercise, muscle contraction increases blood glucose capture to complement in-
tramuscular glycogenolysis. To replenish glycogen stores, resting muscle captures glucose
postprandially depending on circulating insulin. After exercise, both pathways increase
glucose capture towards the muscle [13]. It has also been observed that exercise improves
blood glucose control and quality of life, reduces cardiovascular risk and contributes to
weight loss [14]. Consequently, exercise-based interventions are beneficial for patients with
diabetic neuropathy.
Various systematic revisions have indicated that manual therapy is beneficial in
improving function and symptoms in patients with peripheral neuropathies [15–17]. In
a study with rats, Zhu et al. [4] observed the impact of these oscillations on diabetic
neuropathy using mobilisations of the sciatic nerve. The authors found an attenuation of
allodynia in the treatment area and a reduction in pro-inflammatory mediator concentration
in the sciatic nerve branches.
In spite of the elevated prevalence of peripheral neuropathy and its major involvement
in the morbidity of patients with diabetes, it is the chronic complication for which the
least information is available about its pathogeny and epidemiology, and the one with the
fewest standardised study methods. Additionally, no systematic review on its therapeutic
management, including manual therapy and exercise, was found [9]. The aim of this
study was to review the effectiveness of manual therapy and/or exercise in patients with
diabetic neuropathy.
2. Materials and Methods
2.1. Protocol and Registry
A systematic review following the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) [18] criteria was designed. This review was registered on
the Open Science Framework digital platform with doi:10.17605/OSF.IO/3FS92 (https:
//osf.io/3fs92/, accessed on 3 March 2021).
2.2. Search and Information Sources
The search strategy followed the Population, Intervention, Comparison, Outcome and
Study type (PICOS) method. Population was defined as individuals with diabetic neu-
ropathy; Intervention, as manual therapy and/or exercise; and Comparison, as comparing
with the control group and/or placebo and/or other conservative treatment. Outcome
was found using outcomes related to balance, motor and sensory functions, and/or pain.
Study type was limited to controlled clinical trials. The following databases were searched:
PubMed, PEDro, Cochrane Library, Scopus and Web of Science. Various search strate-
gies were used depending on the database and the filters permitted. The MESH terms
used were “Diabetes Mellitus”, “Diabetes Complications”, “Peripheral Nervous System
Diseases”, “Diabetic Neuropathies”, “Musculoskeletal Manipulations”, “Therapy, Soft
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Tissue”, “Manual therapy”, “Physical Therapy”, “Resistance Training” and “Exercise Ther-
apy”. The Boolean terms “OR” and “AND” were used to achieve a better search. Table 1
shows the search strategies used for each database. Search period was settled as between
26 November 2020 and 20 January 2021.
Table 1. Search strategy.
Database Search Strategy Filters
PubMed
“Diabetes Mellitus” [Mesh] AND (“Diabetes
Complications” [Mesh] OR “Peripheral Nervous
System Diseases” [Mesh] OR “Diabetic
Neuropathies” [Mesh]) AND (“Musculoskeletal
Manipulations” [Mesh] OR “Therapy, Soft Tissue”
[Mesh] OR “Manual therapy” OR “Physical
Therapy” OR “Resistance Training” [Mesh] OR
“Exercise Therapy” [Mesh])
- Availability: Full text.
- Article type: Clinical. Trial: Randomised
controlled trial.
- Language: English, Spanish, French, Italian.
Web of Science
“Diabetes Mellitus” AND (“Diabetes Complications”
OR “Peripheral Nervous System Diseases” OR
“Diabetic Neuropathies”) AND (“Musculoskeletal
Manipulations” OR “Therapy, Soft Tissue” OR
“Manual therapy” OR “Physical Therapy” OR
“Resistance Training” OR “Exercise Therapy”)
- Document type: Article.
- Language: English, Spanish, French, Italian.
SCOPUS
“Diabetes Mellitus” AND (“Diabetes Complications”
OR “Peripheral Nervous System Diseases” OR
“Diabetic Neuropathies”) AND (“Musculoskeletal
Manipulations” OR “Therapy, Soft Tissue” OR
“Manual therapy” OR “Physical Therapy” OR
“Resistance Training” OR “Exercise Therapy”) AND
“Clinical Trial”
- Document type: Article.
- Language: English, Spanish,
French, Italian.
- Source type: Journal.
Cochrane Library
“Diabetes Mellitus” AND (“Diabetes Complications”
OR “Peripheral Nervous System Diseases” OR
“Diabetic Neuropathies”) AND (“Musculoskeletal
Manipulations” OR “Therapy, Soft Tissue” OR
“Manual therapy” OR “Physical Therapy” OR
“Resistance Training” OR “Exercise Therapy”)
- Trials.
- Language: English, Spanish, French, Italian.
PEDro “diabetic neuropathy”
- Therapy: Fitness training (9), skills training
(6), strength training (2), “stretching,
mobilization, manipulation, massage” (2).
- Type publication: Clinical trial.
- When searching: Match all search
terms (AND).
2.3. Eligibility Criteria
Inclusion criteria were: (1) controlled clinical trials that compared a manual therapy
and/or exercise group with a control group and/or placebo group and/or other conserva-
tive treatment; (2) studies in which the sample included patients diagnosed with diabetic
neuropathy; (3) studies that focused on pain, sensory and motor function, and balance out-
comes; and (4) studies published in English, French, Italian or Spanish. Exclusion criteria
were studies for which (1) surgery was contemplated as a selection and/or intervention
process; or (2) another approach was used, except if it was in the context of comparing it
with manual therapy or exercise techniques.
2.4. Selection of Studies
Two different authors (M.H.-S. and M.O.L.-L.) selected and extracted the data inde-
pendently. They searched the references sources and screened the titles, abstracts and
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complete text, following the eligibility criteria. If there were any discrepancies in opinions
or any doubts, a third author (C.H.-G.) was consulted to resolve them.
2.5. Data Extraction Process
For each study, the following information was extracted: (1) author and the year of
publication; (2) sample definition; (3) inclusion criteria; (4) exclusion criteria; (5) groups;
(6) intervention; (7) dose; (8) outcome; and (9) results.
2.6. Risk of Bias in Individual Studies
The Physiotherapy Evidence Database (PEDro) scale and Cochrane’s Risk of Bias 2
(RoB 2) tool were used to evaluate the methodological quality of the clinical trials. The first
instrument, the PEDro Scale, conforms to the Delphi list, based on the consensus of experts
to help the reader to identify clinical trials with sufficient internal validity and statistical
information to make their results interpretable. It consists of 11 criteria to answer, using
“Yes” or “No”. Each criteria fulfilled receives 1 point, if the information is clearly expressed
in the study; the maximum score is 11 points [19].
The RoB 2 tool is Cochrane’s second version for evaluating the risk of bias in clinical
trials. The biases are assessed in 5 different domains, as follows: (1) randomisation process;
(2) effect of assignment to the interventions; (3) data from the outcome; (4) outcome
measurement; and (5) results reported. Within each domain, there are 1 or more questions
to which to respond. The answers lead to judgements of “low risk of bias”, “some concerns”
or “high risk of bias” [20]. The tables and charts presenting the results obtained with RoB 2
were created using the risk-of-bias visualisation (robvis) tool [21].
3. Results
3.1. Selection of Studies
The literature search returned 656 articles (PubMed: 113, Web of Science: 5; Sco-
pus: 466; PEDro: 19; Cochrane: 53). After eliminating duplicates, 566 articles remained
for analysis.
The first analysis focused on article titles and abstracts, with 492 being excluded for
study design, sample, lack of complete article and interventions other than manual therapy
and/or exercise.
The 72 articles remaining were then analysed to select those that fulfilled the inclusion
criteria. Of these, 29 articles were selected for analysis. The selection process is shown in a
PRISMA diagram flow (Figure 1).
3.2. Study Characteristics
3.2.1. Sample
The study characteristics and sample selection are described in Tables 2 and 3. All
the articles offer a sample of 1476 patients. There were 14 articles that specified that the
diabetes had to be type 2 [22–35]; the rest of the articles did not specify which type of
diabetes should be selected for the sample.
Most of the articles included patients from 45 to 65 years old. There were 16 articles
that included patients aged over 40 years [22,24–26,28,29,33–42]. In addition, six articles
included patients older than 18 [23,43–47], while seven did not specify the age for the
selection of their sample [27,30–32,48–50].
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Blood analyses taking HbA1c as a reference (cut-off value ≥ 6.5%) and blood glucose
levels (cut-off value ≥ 7.0 mmol/L or ≥120 mg/dL fasting value and ≥11.1 mmol/L or
≥200 mg/dL postprandial value); the Michigan questionnaire for neuropathies; and the
American Diabetes Association criteria [50] were the criteria most used for the diagnosis
of diabetic neuropathy. Three studies included an electrodiagnostic test to confirm the
presence of neuropathy [25,35,45]. Other criteria observed in the different studies were
physical examination tests, vibratory threshold, sensitivity to fine touch and physical skills.
oreover, the typology of diabetic neuropathy is specific in a few articles, being
described as peripheral neuropathy.
3.2.2. Intervention
There were 22 articles that included an intervention group with exercise [23,25–34,36–
42,46,47,49,50] and six articles included an intervention group with manual therapy [22,24,
43–45,48], while one article combined both interve tions [35].
Ex rcise
The maj rity of the studies compar d an exercise group with a control group, im-
plementing patient education or standar care. Four studies included t ree group in
their analysis: two intervention groups and one control group [23,34,37,47]. The inter
vention groups were mainly different proposals for types of exercise. The exception was
Serry et al. [34], who compared exercise with TENS. Ten studies considered another type of
training as a control group or considered two intervention groups directly [23,30–32,34,36,37,47].
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Table 2. Selection criteria of the studies.
Study N (H/M) Inclusion Criteria Exclusion Criteria
a. Exercise Intervention
Ahmad (2020) 38 (25/13)
- 45–75 y.
- >7 y of diabetes.
- BMI 18,5–29,9
- >2/13 MSNI questionnaire (2 sympt. characteristic of DPN).
- >1/10 MNSI (↓ vibration, without plantar ulcers, without part or
complete amputation, ability to walk short distances independently).
- Other neurologic impairment.
- Major vascular complication.
- Severe retinopathy.
- Severe nephropathy.
- Severe lower limb msk impairment.
- Cardiovascular implication.
- Not physical therapy.
Ahmad (2020) 37 (24/13)
- 45–75 y.
- >7 y of diabetes.
- BMI 18.5–29.9.
- >2/13.
- >2/13 MNSI questionnaire.
- >1/10 physical assessment (↓ sensorial vibration).
- Plantar ulcers.
- Lower limb surgical and orthopaedic problems.
- Other neurologic impairment.
- Major vascular complication.
- Severe retinopathy.
- Inability to walk independently with or without an
assistive device.
- Not physical therapy.
Cox (2020) 32 (19/13)
- 18–80 y.
- Type 2 diabetes.
- HbA1c > 6.0% or fasting glucose level >7.0 mmol/L.
- American College of Sports Medicine’s absolute
contraindications to exercise.
- Unstable angina.
- Recent myocardial infarction.
- Uncontrolled coronary artery diseases.
- Symptomatic heart failure.
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Table 2. Cont.
Study N (H/M) Inclusion Criteria Exclusion Criteria
Dixit (2016) 82 (-)
- 50–70 y.
- Type 2 diabetes.
- Peripheral neuropathy: >7 MDNS.
- Vitamin B12 deficiency.
- Postural hypotension.
- Foot ulcers.
- Walking with assistive device.
- Part or complete foot amputation.
- Peripheral arterial disease.
- Vision impairments.





- Known cardiac risks.
- Recent history of active retinal haemorrhage or a recent
laser therapy (<6 m) for retinopathy.
- Recent vascularisation of coronary artery bypass grafting
(<3 m).
- Seeking other therapies in DPN.
Grewal (2015) 35 (16/19)
- 50–80 y.
- Ability to walk independently for 20 m.
- Medical diagnosis of type 2 diabetes.
- DPN: criteria of American Diabetes Association statement,
insensitivity to 10 g SWM, <25 V VPT.
- Cognitive, vestibular or central neurological dysfunction.
- Msk abnormality.
- Active foot ulcers.
- Charcot’s joints.
- History of a balance disorder unrelated to DPN.
Jannu (2017) 50 (28/22)
- Type 2 diabetes 4–8 y.
- Lower limb muscle strength not less than grade 3.
- Moderate neuropathy: 9–11 Toronto scale.
- BBS 35–45 score.
- TUG <15 s.
- Plantar ulcer and foot problems.
- Any vestibular disorder.
- History of any orthopaedic complications.
- History of any neurological complications.
- Any hearing and visual defects.
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Table 2. Cont.
Study N (H/M) Inclusion Criteria Exclusion Criteria
Kanchanasamut
(2017) 21 (-)
- Medical diagnosis of type 2 diabetes.
- Loss of feeling.








- Previous bypass surgery/angioplasty.
- Foot/leg amputation.
- Current or previous foot ulceration.
- Reduced palpability of dorsalis pedis and tibialis
posterior arteries.
- Participation in regular weight-bearing exercise.
Kiani (2018) 38 (14/24)
- >40 y.
- >1 y diabetes.
- Stable blood glucose control.
- Foot ulceration.
- Unstable heart disease.
- Co-morbid conditions limiting exercise.
- Any other disorder of the CNS causing weakness and
sensory loss.
Kuo (2019) 38 (21/17)
- Medical diagnose of type 2 diabetes: American Diabetes
Association criteria.
- >26.5 pinch strength.
- Neuro–msk disorders.
- Traumatic nerve injuries of the upper limbs.
- Trauma to the hand or congenital. anomalies of the wrist
and hand.
- Skin infections or disease of the hands.
- Cognitive deficits.
- <20 y.
Lee (2017) 60 (37/22)
- >65 y.
- One or more falls within the past 12 months.
- Physician’s diagnosis of DPN.
- Msk abnormalities.
- Inability to stand independently.
- Neurological impairment.
- <24 Mini-Mental State Examination Score.
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Table 2. Cont.
Study N (H/M) Inclusion Criteria Exclusion Criteria
Lee (2013) 55 (24/31)
- >65 y.
- Two or more falls during the previous 12 months/1 fall + >15 s
TUG/recurrent unexplained falls.
- Msk impairment (inability to walk independently).
- Vision impairment.
- Neurological impairment.
- Vestibular diseases with diabetes-related etiology.
- Dementia: <24 Mini-Mental.
- Participation of <80% of the exercise program.
- Unable to perform follow-up test.
Mueller (2013) 29 (17/12)
- Type 2 diabetes.
- PN: inability to sense 5.07 SWM in at least 1 spot of plantar foot, <25
V VPT at plantar great toe.
- Step count 2000–9000 steps/day.
- Currently exercising <3 t/wk.
- <20 min/ss.
- >138 kg.
- Severe foot deformity that requires custom
therapeutic footwear.
- Comorbidity.
- Medication that interferes with ability to exercise,




- Type 2 diabetes.
- Diffuse symmetrical sensory motor neuropathy.
- Ability to walk without assistance or walking aid.
- Strength of knee and ankle muscles grade 3 or greater by
manual testing.
- Uncontrolled diabetes (blood glucose levels <5.5 or
>14 mmol/L).
- Retinopathy.
- Coronary artery disease and a history of angina or
angina-equivalent symptoms.
- Uncontrolled hypertension (systolic >160 mmHg and
diastolic >90 mmHg).
- Autonomic neuropathy.
- A history of central nervous system dysfunction
(hemiparesis, myelopathy, cerebellar ataxia).
- Msk deformity (amputation, scoliosis and inability to
actively move ankle and knee joints in all directions).
- Lower extremity arthritis or pain that limited standing.
- A history or evidence of vestibular dysfunction upon
physical examination.
- Foot ulcer.
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Table 2. Cont.
Study N (H/M) Inclusion Criteria Exclusion Criteria
Quigley (2014) 99 (15/84)
- >18 y.
- Able to ambulate household distances with or without an assistive
device, symptoms consistent with DSP (symmetric, distal lower
limb numbness or altered sensation).
- PN: >7 MDNS.
- Cognitive impairment: <24 Mini-Mental.
- Severe disease: metastatic cancer, central
neurologic dysfunction.
- Lower limb amputation.
- Lower limb motor weakness (less than antigravity).
- Mobility limitation caused by altered lower extremity skin
integrity/ulcer.
- Medically unstable condition (uncontrolled hypertension,




- Diabetes mellitus treated by diet, oral hypoglycaemic or insulin.
- Lower extremity symptoms consistent with PN.
- Ability to walk household distance without assistance or an
assistive device.
- Strength of ankle dorsiflexors, invertors and evertors at
least antigravity.
- Conclusive electrodiagnostic evidence of a diffuse, primarily axonal,
peripheral polyneuropathy: sural response (A < 6 yV with a normal
or minimally prolonged distal latency (<5 ms)); peroneal/tibial
responses (A < 2 mV for peroneal and <3 mV for tibial with a
normal distal latency (<6.5 ms)).
- Significant central nervous system dysfunction
(hemiparesis, myelopathy, cerebellar ataxia).
- Significant msk deformity (amputation, scoliosis,
abnormality or ROM).
- Lower extremity arthritis or pain that limits standing or
weight-bearing exercise.
- Electrodiagnostic evidence of any diagnosis other than PN.
- History or evidence of vestibular dysfunction upon
physical examination.
- History of angina or angina-equivalent symptoms.
- Symptomatic postural hypotension.
- Plantar skin pressure ulcer.
Serry (2016) 60 (28/32)
- 45–60 y.
- >10 y type 2 diabetes mellitus.
- >5 y DPN.
- Ambulant and independent.
- HbA1c < 6.5%.
- >4 strength lower limb.
- BMI 18.5–29.9 kg·m−2.
- Life-threatening diseases: renal failure, myocardial
infarction, heart failure.
- Sensory manifestations due to other disease: lumbar
disc prolapsed.
- Circulatory problems: intermittent claudications, skin
diseases or foot ulcers.
- BMI >30 kg·m−2.
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Table 2. Cont.




- DPN: MDNS and 10-point SWM.




- Severe retinopathy, dialysis and neuropathy.
- Upper body neuropathy or arthritis that could help reduce
and/or limit the pain.
- Existence of imbalance factors except for neuropathy.
Song (2011) 38 (15/23) - Physician-diagnosed DPN.- Diabetes.
- Msk impairments (inability to walk independently, lower
extremity strength grade 3, fracture or malformation).
- Severe osteoarthritis.








- DPN: clinical evaluation, diabetic neuropathy index criteria, SWM,
toe vibration).
- >3 type 2 diabetes.
- Walk autonomously.
- <5 FIM locomotion scale.
- Articular ankyloses, contractures, spasms with
locomotion effects.
- Bone instability affecting lower limb functionality.
- Clinicopathologic conditions contraindicating
rehabilitation treatment.
- Cutaneous lesions at lower limb.
- <22 Mini-Mental.
- Behavioural diseases involving aggressiveness or
psychotic disorders.
Toth (2014) 54 (22/32)
- 18–80 y.
- >6 m neuropathic pain associated with DPN: >4 DN4, neurologist
diagnosed, >40 mm VAS McGill Pain Questionnaire.
- Willingness to be enrolled in either exercise or educational sessions.
- Perceived ability to walk on a flat surface or treadmill for at least 1
km/d at time of enrolment on behalf of the patient and
enrolling physician.
- Another non-NeP source of pain that is more dominant
than the peripheral NeP or that cannot be
separated clinically.
- <6 m NeP.
- Central nervous system cause of pain.
- Absence of other health conditions: cardiovascular or
pulmonary disease, severe obesity, amputation, use of
mobility assistive devices or active neoplasia.
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Table 2. Cont.




- DPN: 25 V neurothensiometer, positive monofilament test in >2 sites
of foot, >7 MDNS).
- Type 2 diabetes.
- Foot ulceration/infection/amputation.
- Contraindication for physical activity or physiotherapy.
- Non-diabetic neuropathy.
- Alcohol abuse.
- Non-diabetes- and non-neuropathy-related orthopaedic,
surgical or medical conditions affecting functional mobility
and balance.
Win (2020) 75 (18/57)
- DPN.
- Type 2 diabetes.
- Antihyperglycemic medication.
- Neuropathy non-related to diabetes.
- Retroviral infection, stoke or antipsychotic and
antituberculosis treatment.
- Amputated hands and feet.
- Mental illness.
- Alcoholism.





- Impaired level of diabetic foot: peripheral sensory deficit SWMT on
3rd and 5th toes, head of 1st and 3rd metatarsi; ability to walk 10 m
without walking aid.
- Parkinson’s disease and stroke.
- Severe cognitive disability.
- Acute illness, unstable hypertension and angina.
- Myocardial infarction.
- Fracture of the lower limb within 6 months before
the study.
- Foot deformity and neuroarthropathy.
- Foot ulcer.
- Dependence on alcohol/drugs.
- Partial or complete blindness.
Dalal (2014) 58 (31/27) - DPN: HbA1c > 6.5%, fasting plasma glucose level >120 mg/dL andpostprandial >200 md/dL.
- End organ damage due to diabetes/any cause.
- Chronic disorders: malignancy, tuberculosis, asthma,
communicable disease.
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Table 2. Cont.




- DP4 > 4 pt.
- No history of other causes of NeP.
- Hand or foot wounds or previous related surgery.
- Irritation.
- Ulceration.
- Soft tissue infection.
- Essential oil allergies.
- Blood coagulation disorders.
- Pregnant.
Singh (2012) 30 (30/0)
- 40–65 y.
- VPT > 25 V.
- >3 y type 2 diabetes.
- Bilateral DPN.
- Antihyperglycemic drug (glimepride).
- Poor glycaemic control.
- Baker cyst.
- Autonomic disease.
- History of trauma.
- Any neurological disorder.
- Leprosy/skin disease.
- Nerve sheath ganglia.





Talebi (2018) 30 (-)
- 30–65 y.
- CTS diagnosed by a neurologist.
- Complaint of pain and paresthesia in the distribution of median
nerve within the hand for at least 6 months.
- Positive tinel sign and phalen sign.
- >2 y diabetes.
- History of carpal tunnel release.
- Previous steroid injection.
- Cervical radiculopathy.
- Metabolic disorders other than diabetes.
- Pregnancy.
- History of neck/shoulder or arm trauma and atrophy of
thenar muscles.
Xie (2019) 119 (63/56)
- 18–80 y.
- Type 1 or 2 diabetes.
- Primary diagnosis of DPN: impaired light touch by 10g SWMT,
VPT > 16 V each foot, >6 Toronto Clinical Scoring System.
- No foot ulcers or active signs of skin disease.
- Cardiovascular or mental illness.
- Non-diabetic peripheral nephropathy.
- Ketacidosis or hyperosmolar coma.
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Table 2. Cont.





- Type 2 diabetes.
- DPN.
- Sedentary + able to walk 1–6 km distance without assistance.
- Medication of metformin (500 mg, 2 t/d) + glibenclamide (5–10 mg
fasted state).
- Central nervous system dysfunction.
- Significant msk deformity or pain that limits exercise.
- Severe cardiovascular diseases.
- Vestibular dysfunction.
- Angina-equivalent symptoms.
- Plantar skin pressure ulcers.
BMI: body mass index; CTS: carpal tunnel syndrome; DPN: diabetic peripheral neuropathy; FIM: functional independence measure; MDNS: Michigan Diabetes Neuropathy Score; mg: milligrams; MNSI:
Michigan Neuropathy Screening Instrument; msk: musculoskeletal; NeP: neuropathic pain; ss: sessions; s: seconds; SWM: Semmes–Weinstein monofilament; PN: peripheral neuropathy; VPT: vibration
perception threshold; y: years.
Table 3. Study characteristics.









- Control: G1 + G2.








- Propioception: front, back,
left, right
- Latency, amplitude, duration
NCV of peroneal and tibial nerve
- %MVIC open, close eyes,
treadmill walking: TA, MG,
VL, MF
- Co-contraction index: stand EO,
EC, gait
G1: +NCV peroneal/tibial;
-Distal tibial latency. EO: TA, MG,
MF t·gp (p < 0.05). ↓MF/↑TA
treadmill. Co-contraction (p < 0.05).
G2: +NCV tibial, +DL tibial.
↑TA-MF treadmill (p < 0.05).
G1 vs. G2: Significant difference in
all proprioception angles for G1.
Balance: Improvement in







- Exercise: 3 t/
wk·8 wk.
- Control: G1 + G2.
30 min·1 t·2 wk.
- Exercise: Core +
balance + gait pattern
- 10 min warm-up +





- OLS: EO, EC right; EO, EC left
- COP range: front, back left, right
- COP sway VF: F–B, L–R
- COP sway WVF: F–B, L–R
- Propioception: front, back
left, right
G1 vs. G2: COP range +
Proprioception front for G1
(p < 0.05). Significantly different t
effect for all outcomes except COP
sway VF F–B, OLS EO right.
Effect—age for OLS EO-EC left, EC
right, COP sway WVF F–B.
Group—affects all outcomes except
COP sway. T effect—age for OLS
EO-EC left and EC right. (p < 0.05).
Balance: Improvement in
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78 min/wk·3 t/ sem·8 wk.
- Control: G2. 8 wk.
- C-MICT: 2 ss aerobic
(55–69% HRpeak) +
resistance (I moderate);
2 ss aerobic (55–69%
HRpeak).
- C-HIIT: 3 min·50–60%
HRpeak +
4 min·85–95% HRpeak







- HbA1c + fasting glucose
G1: 96.5% adherence.
G2: 97.9% adherence.
G1 vs. G3: Significant difference in
pain intensity for G1 (p < 0.05).
G2 vs. G3: Significant difference in
pain intensity for G2 (p < 0.05).
Adverse effect: C-HIIT ↑risk of











- Exercise: 3–6 t/
wk·8 wk.
- Control: G1 + G2. 1
t·2 wk·8 wk.
- Exercise: I moderate,
between 150 and
360 min/wk.
- Control: Phone calls.
Standard medical care +
education on foot care
and diet.
- EO+ EC: x-axis, y -axis, VM,
AP, ML.
- EOF+ ECF: x-axis, y -axis, VM,
AP, ML.
- Waist circumference.
G1 vs. G2: Significant difference in
oscillatory velocity ECF x-axis and



















- EO + EC: CoM sway, CoM AP
sway, CoM ML sway, ankle sway,
hip sway.
- SF-12.
- Daily physical activities
monitored during 48 h: time spent
sitting, standing, walking,
total steps.
G1: >26.09% improvement in
balance outcomes. Between
−0.04/27.68% of change for SF-12
and ADL.
G2: Between −34.29/23.03% of
change for outcomes.
G1 vs. G2: Significant difference in
EO (not CoM AP sway), EC ankle
sway, SF-12 mental component
for G1. (p < 0.05).
Balance: Improvement in
both groups. Better for G1.
Function: Improvement









- WooB: 45 min·8 wk.
- ST: 45 min·8 wk.




- ST: 30 min
conventional
physiotherapy
+ 15 min ST.
- BBS.
- TUG.
G1: No significant differences
(p > 0.05).
G2: Significant differences (p < 0.05)
for BBS/TUG.
G1 vs. G2: Significant difference for
G2 (p < 0.05).
Balance: Better for G2.
Function: Better for G2.
Pain: Not measured.
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- Exercise: 5 t/wk·2 wk
(each level)·8 wk.





5 min warm-up +
10·10 s + 5 min
cold-down.
- Control: Foot care.
- ROM: flexion, extension 1st MTP
right and left.
- Peak plantar pressure: hallux,
medial and lateral forefoot,
midfoot, heel. Right and left.
G1: Significant improvement
(p < 0.05) flex-Ext 1st MTP (0–8 wk/
0–20 wk); peak plantar pressure
lateral left, medial right forefoot
(0–20 wk/ 8–20 wk); flex 1st MTP
left (8–20 wk).
G2: No significant improvement
(p > 0.05).
G1 vs. G2: Significant difference in
flex 1st MTP (20 wk), ext 1st MTP
left (20 wk), pressure perception left
(8 wk) and vibration left (8–20 wk)
and right (20 wk) for G1 (p < 0.05).
Balance: Better for G1 at
8 and 20 wk.








- Aerobic: 3 t/
wk·6 wk.
- Balance: G2.
30 min·3 t/wk·6 wk.
- Aerobic: 5 min
warm-up + 6 min walk







G1 vs. G2: Significant difference in
BBT (6 wk), FRT and BRT (3 wk/
6 wk) for G1.
Balance: Better for G1 at
3 and 6 wk.
Function: Better for G1 at








30 min·2 t/wk·6 wk.
- Multimodal: G2.






train + diabetes care.





- Maximum pinch strength.
- % of maximum pinch strength.
- MHQ scale.
- Diabetes-39.
G1 vs. G2: Significant difference in
S2PD, D2PD, % and maximum
pinch strength, Purdue Pegboard
Test, Diabetes-39 (control, sexual
function, energy and mobility)
for G1.
Balance: Not measured.










11 min·3 t/ wk·6 wk.
- Strength: G2.
11 min·3 t/wk·6 wk.
- Vibratory: Vibratory
training.






(p < 0.05) in VPT
G2: No significant improvement
(p > 0.05).
G1 vs. G2: Significant differences
(p < 0.05) in VPT for G1.
Balance: Not measured.
Function: Improvement
in G1. Better for G1.
Pain: Not measured.
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60 min·2 t/wk·6 wk.
- BE:
60 min·2 t/wk·6 wk.
- Control: 6 wk.




- BE: 10 min warm-up +










(p < 0.05) in HbA1c, postural sway,
OLS, FRT, BBS, TUG, FTSTS.
G2: Significant improvement
(p < 0.05) in postural sway, OLS, FRT,
BBS, TUG, FTSTS.
G3: No significant improvement
(p > 0.05)
G1 vs. G2: Significant differences
(p < 0.05) in HbA1c, postural sway,
OLS, BBS, TUG, FTSTS for G1.
G1 vs. G3: Significant differences
(p < 0.05) in OLS for G1.
G2 vs. G3: Significant differences
(p < 0.05) in OLS for G2.
Balance: Improvement in
G1 and G2. Better for G1
vs. G2 and G3; of G2 vs.
G3.
Function: Improvement









- WB: 1 h·3 t/
wk·12 wk.
- NWB: 1 h·3 t/
wk·12 wk.




- NWB: Group session.
Exercise in sitting or
lying position with
elastic bands + cycle
ergometer.
- 6MWT.
- Step activity monitoring.
- Foot and ankle ability measure.
- Beck Depression Inventory-II.
- 9-item physical performance test.
- HbA1c.
- Fat-free mass DAX.
- PF peak torque.
- ROM DF.
G1 vs. G2: Significant differences
(p < 0.05) in 6MWD for G1, and in
HbA1c for G2 (p < 0.05).
Balance: Not measured.
Function: Better for G1 in











- Control: G1 + G2. 12
wk.
- Exercise: 10 min
warm-up + 25 min







- Force right and left quadriceps,
hamstrings, DF, PF.
- Blood glucose level, blood
pressure, HR.
G1 vs. G2: Significant differences
(p < 0.05) in all outcomes for G1.
Balance: Not measured.
Function: Better for G1.
Pain: Not measured.
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- FBT: 1 h·1 t/
wk·10 wk.
- TC: 1 h·1 t/
wk·10 wk.
- Control: 1 h·1 t/
wk·1 0 wk.




- TC: 10 min warm-up +





- Modified Falls Efficacy Scale.
- Spatiotemporal gait variables.
- Balance.
G1: Significant improvement
(p < 0.05) in peak ankle PF power,
peak ground reaction force-anterior
and posterior, step width and
variability.
G2: Significant improvement
(p < 0.05) in TUG, step width and
step time.














2·10 rep·1 t/ d·3 wk.
- Upper quadrant:




raises and heel raises +
bipedal/unipedal
inversion and eversion
+ wall slides + unipedal
balance for time.








(p < 0.05) in all outcomes except
ABC scale.













- Exercise: 50 min·3 t/
wk·8 wk.
- TENS: 30 min·3 t/
wk·8 wk.
- Control: 8 wk.
- Exercise: 5 min
warm-up + 40 min








(p < 0.05) in VAS.
G2: Significant improvement
(p < 0.05) in VAS.












- Exercise: 3 t/
wk·8 wk.
- Control: 8 wk.
- Exercise: 15 min
warm-up + 8–12 rep
resistance training +
3 min interval aerobic





- -30 s bicep curl test.
- Rikli and Jones Chair Stand Test.
- KLC1.
G1: Significant improvement
(p < 0.05) in lower limb strength.
G2: Significant improvement
(p < 0.05) in lower limb strength.
G1 vs. G2: Significant differences
(p < 0.05) in aerobic resistance and




in G1 and G2. Better
for G1.
Pain: Not measured.
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- Exercise: 2 t/
wk·8 wk//Education:
50 min·1 t/wk·8 wk.
- Control: 8 wk.
- Exercise: 10 min
warm-up + 40 min





- Postural sway path: EO AP, EO
ML, EO TS, EC AP, EC ML, EC TS.
- OLS test: EO LT, EC LT, HRLT, EO
RT, EC RT, HRRT.
- BBS.
- FRT.
- 10 m walk.
- EO, EC stable surface, EO foam.
G1: Significant improvement
(p < 0.05) for all outcomes.











- Exercise: 20 s·5
t/wk·4 wk.
- Control: 4 wk.
- Exercise: 20 min
treadmill + 20 min
isokinetic strength +
20 min balance.
- Control: Standard care.
- 6MWT.
- 10 m walking.
- FIM.










(p < 0.05) in 6MWT, FIM, SpO2.
G2: Significant improvement
(p < 0.05) in 6MWT, FIM, SpO2.
G1 vs. G2: Significant differences in
Tinneti scale walk and FEO2 for G1
(p < 0.05).
Balance: Improvement in
G1 and G2. Better for G1.
Function: Improvement










- Control: 2 h·1 t/
wk·6 m.



























- Exercise: 1 t/
wk·8 wk.
- Control: 8 wk.










G1 vs. G2: Significant differences in
HRQoL pain, TUG, FTSTS, ABC
scale, muscular strength (ankle and
knee) for G1 (p < 0.05).
Balance: Better for G1.
Function: Better for G1.
Pain: Better for G1.
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- Exercise: 10 min·3 t/
d (rest 2 d/wk)·8 wk.
- Control: G1 +
G2. 8 wk.











G1 vs. G2: Significant differences in
PNQ (motor area) for G1 (p < 0.05).
Balance: No significant
difference.
Function: Better for G1.
Pain: No significant
difference.







30 min·3 t/wk·2 wk.
- Control: 30min·3 t/
wk·2 wk.
- Thai Massage: 25 min
massage (3–5.5–10 s
maintain pressure +
gentle pulls of toes) +
5 min stretching.
- Control: Educational
sessions of foot care +




- ROM: 1stt MTP, ankle, knee.
- SWM.
G1: Significant improvement
(p < 0.05) in all outcomes at 1–2 wk,
except OLS and SWMT on 1 wk.
G2: Significant improvement
(p < 0.05) in ROM after 1 wk and all
outcomes after 2 wk.
Balance: Improvement in
G1 at 1 wk.
Function: Improvement







30 min·2/ d·1 t/m·5 m.
- Control: G1 + G2 5 m.
- Reflexology: 15 stimuli













(p < 0.05) in all outcomes.
G2: Significant improvement
(p < 0.05) in all outcomes.
G1 vs. G2: Significant differences in
all outcomes for G1 (p < 0.05).
Balance: Not measured.
Function: Improvement
in both groups. Better for
G1.
Pain: Improvement in







Aromatherapy: 30 min·12 s·3 t/
wk·4 wk
- Control: 4 wk
- Aromatherapy: 20 min
massage feet + 10 min
hands with essential oil.






(p < 0.05) for VAS, QoL.
G2: No significant improvement
(p < 0.05).
G1 vs. G2: Significant differences for
VAS and QoL for G1 (p < 0.05).
Balance: Not measured.
Function: Improvement
in G1. Better for G1.








- Control: 21 d






- VPT: 1st, 3rd, 5th metatarsal head.
G1 vs. G2: Significant differences
for VPT 1st MTP right head for G1
(p < 0.05).
Balance: Not measured.
Function: Better for G1.
Pain: Not measured.
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25 min·3 t/ wk·4 wk.






palmar fascia release of
the hand, soft tissue
manipulation in the




- TENS: 20 min at 80Hz
60us pulse duration.
Comfortable tingling +




- MNT: angle of elbow.
G1: Significant improvement
(p < 0.05) in all outcomes.
G2: Significant improvement
(p < 0.05) in VAS and BCQT-SSS.
G1 vs. G2: Significant differences in
SSS, FSS and MNT for G1 (p < 0.05).
Balance: Not measured.
Function: Improvement








- Gua Sha therapy:
60 min·12 s·1 t/
d·4 wk.
- Control: 4 wk.
- Gua Sha therapy: Gua
Sha Oil massage along
midline of the back
with Gua Sha tool.




- Fasting plasma glucose.
G1: Significant improvement
(p < 0.05) in all outcomes and
follow-ups.
G1 vs. G2: Significant differences in
VPT and ABI (4 wk); all outcomes
(8/12 wk) for G1 (p < 0.05).
Balance: Not measured.
Function: Improvement
in G1. Better for G1.
Pain: Improvement in G1.
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60 min·3 t/wk·8 wk.
- Massage: 30 min·3 t/
wk·8 wk.
- Control: 8 wk.
- Aquatic exercise:
10 min warm-up +
40 min walking,
balance and lower















- Fasting blood sugar.
- Nerve growth factor.
- BBS.
G1: Significant improvement
(p < 0.05) in nerve growth factor and
BBS, and between G4 in favour of
G1.
G2: Significant improvement
(p < 0.05) in all outcomes and
between G4 in favour of G2.
Signficant difference in BBS and
nerve growth factor between G1 and
G3, in favour of G2.
G3: Significant improvement
(p < 0.05) in nerve growth factor and
BBS.
Balance: Improvement in
G1, G2 and G3. Better for
G1 and G2 vs. G4, and G2
vs. G1 and G3.
Function: Improvement
in G1, G2 and G3. Better
for G1 and G2 vs. G4, and
G2 vs. G1 and G3.
Pain: Not measured.
6MWT: 6 m walking test; ABC scale: activities-specific balance confidence; ABI: Ankle Brachial Index; ADL: Activities of Daily Living; AP: anteroposterior; BBS: Berg Balance Scale; BBT: Berg Balance Test; BCTQ:
Boston Carpal Tunnel Syndrome Questionnaire; BE: balance exercise; BRT: Backward Release Test; CGI: Clinician Global Impression Scale; C-HIIT: combined high-intensity interval training; C-MICT: combined
moderate-intensity continuous training; CoM: centre of mass; COP: centre of pressure; CPT: cold pain threshold; DBP: diastolic blood pressure; DF: dorsal flexion; EC: eyes closed; EO: eyes open; ECF: EC on
foam; EOF: EO on foam; EQ-5D: EuroQol 5 Domains; FBT: functional balance training; F–B: front–back; FEO2: fraction of expired air that is oxygen; FIM; functional independence measure; FRT: forward reach
test; FTSTS: five-times-sit-to-stand test; FPpeak: maximum pinch force during the lifting phase; HADS: Hospital Anxiety and Depression Scale; HRLT: left leg standing EO and head rotation; HRRT: right leg
standing EO and head rotation; HRpeak: heart rate peak; HPt: heat pain threshold; IPAQ: International Physical Activity Questionnaire; KPS: Karnofsky Performance Scale; m: months; min: minutes; LT: left leg
standing; L–R: left–right; M2PD: Moving two-point discrimination; MBPI: modified Brief Pain Inventory short form; MF: Mulifidus; MG: Medial gastrocnemius; MHQ: Michigan Hand Outcomes Questionnaire;
ML: mediolateral; MNT: Medial nerve test; MOSSS: Medical Outcomes Study Sleep Scale; MTP: metacarpophalangeal; MVIC: Muscle voluntary isometric contraction; NCV: Nerve conduction velocity; NMQ:
Nordic Musculoskeletal questionnaire; NPSI: Neuropathic Pain Symptom Inventory; NTSS-6: 6-ittem Neuropathy Total Symptom Scale; NWB: non weight-bearing; OLS: One-leg standing; PF: plantar flexion;
PTSS: Pain treatment Satisfaction Scale; PGIC: Patient Global Impression of Change; PNQ: Patient Neurotoxicity Questionnaire; QTS: Quantitative sensory testing; REE: resting energy expenditure; ROM: Range
of movement; RR: respiratory rate; RT: Right leg standing; S2PD: static two-point discrimination; SBP: systolic blood pressure; SF-12: Short-form health survey; ss: sessions; SpO2: oxygen saturation; ST: Stability
trainer; SWM: Semmes-Weinstein monofilament; t: time; TA: Tibialis anterior, TC: Tai-Chi; TCSS: Toronto Clinical Scoring System; TENS: transcutaneous electrical nerve stimulation; TS: Total body sway; TUG:
Timed up and go test; VAS: Visual analog scale; VE: expired minute volume; VF: visual feedback; VL: Vastus lateralis; VM: velocity moment; VO2max: maximal oxygen consumption; VPT. Vibration perception
threshold; WB: weight-bearing; WBV: whole-body vibration; wk: week; WooB: Wooble Board; WVF: without visual feedback.
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The principal forms of exercise were balance work, aerobic exercise and strength
exercises. There were 12 articles that developed various programmes to work on bal-
ance [26,27,29–31,36–38,40,41,47,50]. In this group, the studies included programmes
focused on balance, sensory–motor exercises, gait exercises, bio-feedback and unstable
platforms. Seven articles developed aerobic-type training [23,28,34,39,42,46,49]. These
exercises were generally carried out at medium intensity using a treadmill or stationary
bike. Lastly, four articles used strength exercises as the basis of their training [25,26,32,33].
The strength exercises were differentiated between using body weight or not, or strength-
resistance training.
The variables used to analyse the results of this subgroup were mainly aimed at
assessing balance. The assessments most used to analyse balance were as follows: postural
sway was measured in seven articles [28,29,40,41,47,49,50]; the Berg Balance Test (BBT)
was used in five articles [30,37,39,47,49]; the Timed Up and Go (TUG) test was used in five
articles [26,27,30,37,47]; the Functional Reach Test (FRT), in four articles [36,37,39,49]; and
the Five-Times-Sit-to-Stand (FTSTS) test, in two articles [26,37]. Other tests such as the
ABC scale, the one-leg stance, the Tinnetti test and tandem test were also used to assess this
outcome. Ten articles analysed function [23,25–27,29,31,32,38,46,50], using the Short Form-
12 Quality of Life (SF-12), the Neuropathy Total Symptom Score-6 (NTSS-6), health-related
quality of life (EQ-5D) or the Functional Independence Measure (FIM) questionnaires, or
tests such as quantitative sensory and range of movement tests. Pain was analysed in three
studies using a visual analogue scale (VAS) [27,34,46]. Strength capacity was analysed
in seven articles [23,25,29,32,42,46,49] by means of the 6-Minute Walk Test (6MWT), the
International Physical Activity Questionnaire (IPAQ), the maximum volume of oxygen
consumption or the 10-Meter Walk Test.
The programmes focused on balance were compared with control groups with patient
education and/or routine care, and statistically significant intra- and intergroup improve-
ments were shown. In addition, the training that included vibration showed statistically
significant differences as compared with a strength programme [38] or programmes with-
out vibration [37]. Jannu et al. [30] added the wobble board against a balance programme,
but they did not find statistically significant improvements in that group. This study
used physiotherapy in both interventions. Training with a mini trampoline also observed
statistically significant differences compared with a control group [50].
Aerobic training was also compared mainly with control groups; statistically signif-
icant differences in favour of the intervention group were found [28,42,46,49]. Cox et al. [23]
observed that an exercise programme of high-intensity interval training (HIIT) and moderate-
intensity continuous training (MICT) showed improvement and significant differences
in pain as compared with a control group. However, HIIT training might involve ad-
verse effects if it exceeds 100 h of training. Turning to another focus, it seems that tread-
mill and stationary bike training is more effective than a balance training group [39].
Lastly, Serry et al. [34] observed that both aerobic exercise and electrotherapy improved
pain significantly.
Essentially, strength training was compared with a control group. Mueller et al. [32],
however, compared body-weight strength training with another strength training group
without body-weight strength. They found statistically significant differences in the vari-
able HbA1c in favour of the group with body weight, in the distance covered in the 6MWT
test, and in favour of the group without body weight. The rest of the articles used various
methodologies for strength training: isometrics [33], isokinetic exercises [25] and combined
with balance [26]. All of these were effective in the balance and strength variables compared
with the control group. Furthermore, the study that used isokinetic exercises (in addition)
included a programme focused on stability and aerobic capacity.
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Manual Therapy
Only six articles included manual therapy as the intervention for patients with diabetic
neuropathy. Once again, these studies compared manual therapy with control groups,
which were defined as patient education, standard care or no intervention.
Thai-type massage [22], Gua Sha [43], reflexology [48] and aromatherapy [45] seem
to be more effective in pain and function variables than the control group in patients
with diabetic neuropathy. Treatment using neurodynamics yielded statistically significant
favourable changes in the vibratory threshold in comparison with no intervention in these
patients [24]. Lastly, the combination of articular, neural and soft tissue mobilisation
techniques seemed to be more effective than an electrotherapy protocol in patients with
diabetes having carpal tunnel syndrome [45].
In the case of manual therapy, the variables most used in the studies were pain (by a
VAS scale) in three articles [44,45,48]; vibratory threshold in three articles [24,43,48]; and
other variables linked to function such as questionnaires, sensitivity assessment or range
of motion.
Exercise and Manual Therapy
Just one study [35] analysed the effect of an intervention with aquatic exercise, with
massage and the combination of these two techniques against a control group (no interven-
tion). Shourabi et al. observed statistically significant improvements in all the groups. In
patients with diabetic neuropathy, the combination of aquatic exercise and massage was
more effective for the variables related to balance and physiological factors.
3.2.3. Dosage
In the exercise group, the time used for the exercise programmes ranged from 40 to
60 min. Most of the studies integrated warm-up and cool-down phases (from 5 to 10 min
for each phase) in the intervention process. The total training period was some 60 min of
intervention, principally in the aerobic and balance exercises. In contrast, the programmes
focused on strength involved from 20 to 25 min of training.
As for hours a week, the majority of the protocols were given three times a week.
The greatest number of sessions was once a day, in the study of Richardson et al. [36].
Dixit et al. [28] applied their intervention from 3 to 6 times a week. The minimum number
of sessions per week (once a week) was stipulated in two articles [26,47].
Most of the articles used 8 weeks of follow-up to implement their study progra-
mmes [23,26–28,30,34,35,40–42,49,50]. Other studies had a follow-up of from 3 [36] up to
12 weeks. Toth et al. [46] used long-term follow-ups of up to 6 months, the maximum
period in all the studies.
In the manual therapy group, the intervention period stipulated for all the studies
was 30 min. Only Singh et al. [24], with 10 min for the neurodynamic techniques, and
Xie et al. [43], with 60 min, differed from this period.
Treatment application varied among the articles. Treatment was given three times a
week in three articles [22,44,45]; once a day in two studies [24,43]; and once a week in one
article [48].
All of the studies carried out short-term follow-ups, from approximately 2 to 4 weeks.
However, Dalal et al. [48] had a more long-term follow-up of 5 months.
The study of Shourabi et al. [35], which incorporated manual therapy and exercise
groups into their study, also used the predominant doses in the rest of the studies in
each speciality.
3.2.4. Evaluation of Methodological Quality
The RoB 2 tools show that the features with the worst methodological quality in the
set of studies are the biases in measurement of the variable results, due to deviation from
interventions, with approximately 25% being high risk. The biases from the lack of data
on the variable results and from the selection of the results reported are the domains with
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the best methodological quality in the set of studies, around 75% having a low risk of bias
(Figure 2).
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Table 4. PEDro Scale.
Study 1 2 3 4 5 6 7 8 9 10 11 Total
Ahmad (2020) X X X X X X X X X 9
Ahmad (2019) X X X X X 5
Chatchawan (2015) X X X X X X X X 8
Cox (2020) X X X X X X X 7
Dalal (2014) X X X X X X 6
Dixit (2016) X X X X X X 6
Gok Metin (2017) X X X X X X X X 8
Grewal (2015) X X X X X X X X 8
Jannu (2017) X X X X 5
Kanchanasamut (2017) X X X X 4
Kiani (2018) X X X X X 5
Kuo (2019) X X X X X X X X X 9
Lee (2017) X X X X X X X 7
Lee (2013) X X X X X X X 7
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Table 4. Cont.
Study 1 2 3 4 5 6 7 8 9 10 11 Total
Mueller (2013) X X X X X X X X X 9
Nenkova (2009) X X X X 4
Quigley (2014) X X X X X X X 7
Richardson (2001) X X X X 4
Serry (2016) X X X X X 5
Seyedizadeh (2020) X X X X X X X X 8
Shourabi (2020) X X X X X 5
Singh (2012) X X X X 4
Song (2011) X X X X X X 6
Talebi (2018) X X X X X X X 7
Taveggia (2014) X X X X X X X 8
Toth (2014) X X X X X X X X X 9
Venkataraman (2019) X X X X X 7
Win (2020) X X X X X 5
Xie (2019) X X X X X X X X 8
Mean 6.6
4. Discussion
The objective of this systematic review was to review the effectiveness of manual
therapy and exercise in patients with diabetic neuropathy. We found 29 articles, of which
just one analysed the combination of both techniques. There were six articles that analysed
the effect of manual therapy, while the rest analysed a variety of exercise programmes. We
found a lack of studies that analysed the combination of manual therapy and exercise and
only manual therapy in patients with diabetic neuropathy.
The selection criteria were heterogeneous among the studies. Beginning with sample
age, the articles differed in the minimum age for sample inclusion, from 18 to 40 or 45 years.
The mean age ranges were between 45 and 85 years old. In other reviews, the mean ages
of the patients were between 50 and 60 years old [10,12]. This can be explained by the
elevated diagnosis of diabetic neuropathy in the 51–60-year age group, in patients that
have type 2 diabetes [51,52]. In addition, type 2 diabetes represents the greatest proportion
of the total prevalence of diabetes (90%) and is characteristic of adult patients [53].
In line with the previous point, a great number of the analysed studies specified that
the patients had to have type 2 diabetes, excluding patients with type 1 from the sample.
The studies that include these patients do not provide results based on the type of diabetes
that the patients have. Consequently, it is impossible to determine the effectiveness of these
treatments in those patients and on diabetic neuropathy.
Moreover, the typology of diabetic neuropathy was defined as diabetic peripheral
neuropathy, not considering other types of diabetic neuropathy such as diabetic autonomic
neuropathy, cardiac autonomic neuropathy, gastrointestinal neuropathy and genitourinary
disturbances. These profiles should also be well identified in the selection criteria because
of the problems that exercise can have on patients [14].
Another point to be mentioned is the heterogeneity of the criteria used to diagnose dia-
betic neuropathy. The articles describe the use of the Michigan Diabetic Neuropathy (MDN)
questionnaire, medical diagnoses, sensitivity tests and blood parameters (HbA1c and blood
glycaemia). Nagpal et al. [54] observed that the predictive models for diagnosing diabetic
neuropathy were ambiguous; electrodiagnostic studies do not enable detecting lesions in
fibres of small diameter (which are the most damaged in this type of patient); imaging
tests present different limitations and their usefulness has not yet been demonstrated in
this type of clinical picture; and biomarkers need further studies [55]. Consequently, no
agreement has been reached as to which criterion or criteria should be taken into account
in diagnosing diabetic neuropathy. The studies should unify criteria so as to obtain a
more representative sample that consider the alterations at the level of both large- and
small-diameter nerve fibres.
Appl. Sci. 2021, 11, 5665 27 of 31
We have found considerable variability in the treatment with exercise. This variabil-
ity exists in both the method of exercise and in the analysed variables. All the forms of
treatment (aerobic exercise, balance therapy and strength-resistance treatment, as well as
the combination among them) seem to be effective in improving the signs and symptoms
of patients with diabetic neuropathy. Aerobic exercise, described principally as walking
or using a stationary bike at moderate intensity, significantly improved all the variables
analysed in the studies. Statistically significant differences were shown against control
groups of standard care and/or patient education, but these results were not observed with
groups using TENS interventions. Kiani et al. [39] showed improvements using several
questionnaires in relation to a group treated with balance-focused exercise. In their sys-
tematic review, Gu et al. [56] also found that moderate-intensity aerobic exercise positively
impacted neural function in patients having type 2 diabetes with diabetic neuropathy.
Balance programmes were also developed in a very heterogeneous way. The pro-
grammes using vibration, biofeedback, Tai-Chi and sensory–motor techniques seemed to
have significant improvements after the exercise programme and to have the best ben-
efit compared with control groups of standard care and/or education. Jannu et al. [30]
observed that using the wobble board did not yield any benefits against a stability pro-
gramme. A biofeedback protocol [31] demonstrated significant improvements compared
with a multimodal treatment using tendon gliding, resistance training and patient care.
The programmes that used vibration also had statistically significant improvements in
functional variables as compared with standard strength or balance exercises. In their
systematic review, Ites et al. [57] found that the intervention using exercise centred on
the lower limb was recommendable, for clinical use, in treating balance dysfunction in
diabetic neuropathy. However, they stressed that there were few high-quality studies on
this research area.
In our review, we found that the studies using this type of programme were of
moderate to high quality. Using these programmes makes it possible to conserve motor
control and balance (in spite of sensory deficit) and prevent falls or hyperpressure areas,
avoiding ulcerous processes and amputations of the feet. However, just a single study [30]
included conventional physiotherapy as a complement to balance training, evading the
effects that flexibility or postural re-education programmes can implement to structurally
balance the supports, not only at the sensitive level.
The analysed strengthening programmes also yielded benefits in the signs and symp-
toms of patients with diabetic neuropathy. Although the evidence in this sense is more
scarce, this type of exercise is beneficial (whether in isolation or in combination with the
two previous types of exercise) in balance and function variables. The American Diabetes
Association [14] encourages including strength training for these patients to mitigate neural
symptoms and conserve muscle mass in the elderly, as well as to improve quality of life
and hyperglycaemia control.
Exercise, in all its modalities, is beneficial for patients with diabetic neuropathy, with
high methodological quality of the studies included. However, the variety of the modes
used makes it impossible to identify the most beneficial type of exercise for patients
with diabetic neuropathy. The American Diabetes Association [14] recommends doing
a minimum of 150 min/week of moderate-intensity aerobic exercise or getting 75 min/week
of vigorous aerobics, at a minimum of three times a week with a rest between sessions of no
more than two consecutive days; 2–3 sessions/week of non-consecutive resistance exercises;
and flexibility and balance training 2–3 times/week. Of the studies included in this
systematic review, only five [22,27,33,39,40] reached these recommendations. Furthermore,
the variety of doses used and of follow-ups make it impossible to specify which type of
dosage is the most beneficial for the patients. It would be interesting to design studies based
on the recommendations established by the ADA, as well as monitoring cardiovascular
parameters (altered in this collective) [14].
As for manual therapy, there seems to be a short-term effect of the different types
of massage after treatment in comparison with standard-care and treatment-free control
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groups, with high methodological quality of the studies. In the case of neurodynam-
ics, improvements are also observed after treatment at the vibratory threshold. Lastly,
Talebi et al. [44] observed that an intervention involving articular, neural and soft tissue
presented greater benefits than using TENS in patients with diabetes and carpal tunnel
syndrome, with moderate methodological quality. It should be pointed out that the only
study with medium-term follow-up (5 months) that observed benefits as compared with
conventional drug treatment was the study that was of the highest methodological quality.
As Zhu et al. [58] observed in a study on rats with diabetic neuropathy, using neural
techniques acted on the symptoms and reduced pro-inflammatory cytokines. In addition,
it was observed that patients with type 1 diabetes present increased synthesis of type
III collagen, which reflects the deposit of matrix and connective tissue in the basal mem-
brane [59]. Manual therapy by local intervention may help to control the symptoms. It has
been shown to act at the peripheral, spinal and supra-spinal levels [60]. The mechanical
stimuli that such treatment provides favours the microcirculation in tissues, even in nerves.
Approaching all the surrounding tissues, such as the joint, soft tissue and even the nerve
itself, is more effective against the symptoms because of the increased oxygenation of all
the tissues [61].
Shourabi et al. [35] were the only ones to study the combination of the two modalities.
It was seen that the combination of both was more beneficial than aquatic exercise and
massage alone. However, these results cannot be compared with those of the rest of the
studies due to the different variables evaluated and the moderate quality of the study.
Lastly, due to the limited number of studies that compared both modalities and the diversity
of result variables used to quantify the effects of the techniques, it is impossible for us to
conclude whether the combination of manual therapy and exercise is the most effective for
the treatment of patients with diabetic neuropathy.
The results of this systematic review have some caveats due to the limitations of the
studies included. The lack of homogeneity in the sample selection criteria, along with the
variety of result variables used, make it difficult to compare the studies. Special mention
should be made of the lack of specific reference in the studies to the procedures carried
out for the detection in patients of the possible presence of cardiovascular autonomic
neuropathy. Only two studies [39,41] established it as an exclusion criterion, and did
not specify the diagnostic criteria used for it. Neither did they include the presence of
ischemic heart disease in the exclusion criteria. Examination for cardiovascular autonomic
neuropathy is essential before prescribing exercise because it can be asymptomatic and
detected only by the lack of variability of the heart rate with respiration, and it is associated
with an increased cardiovascular risk [14].
The diversity of exercise modalities and manual techniques also makes objective
comparison of the results difficult. The review itself is subject to limitations stemming from
the wide range of result variables included for analysis.
5. Conclusions
In short, the various modes of exercise and manual therapy are beneficial for patients
with diabetic peripheral neuropathy. Regarding the combination of both therapies, no
conclusion on this hypothesis can be drawn due to the lack of evidence available. Exercise
has been widely studied in its different modalities, but new revisions by modes of exercise,
with similar result variables, should be carried out to establish more specific protocols. As
for manual therapy, the limited number of studies on these patients must be increased in
order to obtain greater knowledge about its effect. Finally, in the face of the benefits from
both techniques separately, increasing the amount of evidence on the effect of combining
them is needed for verifying its potential effectiveness for these patients.
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